Obesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost, safety concerns, and patient acceptance. In the past two decades, endoscopic bariatric and metabolic therapies (EBMTs) have emerged as safe, effective, and less invasive options for the treatment of obesity and its comorbidities, with recent studies reporting favorable outcomes in terms of weight loss and metabolic parameters. This article reviews the major and newly developed EBMTs, with emphasis on their metabolic effects and potential use in the management of metabolic conditions.
CITATION STYLE
Ghazi, R., Vargas, E. J., Abboud, D., Abdul Razak, F., Mahmoud, T., Storm, A. C., … Abu Dayyeh, B. K. (2022). Future of Metabolic Endoscopy. Journal of Digestive Endoscopy, 13(03), 170–178. https://doi.org/10.1055/s-0042-1754335
Mendeley helps you to discover research relevant for your work.